| Edoxaban versus warfarin in patients with atrial fibrillation RP Giugliano, CT Ruff, E Braunwald, SA Murphy, SD Wiviott, JL Halperin, ... New England Journal of Medicine 369 (22), 2093-2104, 2013 | 6065 | 2013 |
| The P-glycoprotein transport system and cardiovascular drugs JD Wessler, LT Grip, J Mendell, RP Giugliano Journal of the American College of Cardiology 61 (25), 2495-2502, 2013 | 425 | 2013 |
| Left atrial structure and function in atrial fibrillation: ENGAGE AF-TIMI 48 DK Gupta, AM Shah, RP Giugliano, CT Ruff, EM Antman, LT Grip, ... European heart journal 35 (22), 1457-1465, 2014 | 232 | 2014 |
| Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study MR McClung, ML O'Donoghue, SE Papapoulos, H Bone, B Langdahl, ... The lancet Diabetes & endocrinology 7 (12), 899-911, 2019 | 155 | 2019 |
| A randomized, placebo-controlled trial to evaluate the tolerability, safety, pharmacokinetics, and pharmacodynamics of a potent inhibitor of poly (ADP-ribose) polymerase (INO … DA Morrow, CM Brickman, SA Murphy, K Baran, R Krakover, H Dauerman, ... Journal of thrombosis and thrombolysis 27, 359-364, 2009 | 104 | 2009 |
| The impact of an end-point committee in a large multicentre, randomized, placebo-controlled clinical trial: results with and without the end-point committee’s final decision on … U Näslund, L Grip, J Fischer-Hansen, T Gundersen, S Lehto, L Wallentin European heart journal 20 (10), 771-777, 1999 | 74 | 1999 |
| Transition of patients from blinded study drug to open-label anticoagulation: the ENGAGE AF–TIMI 48 trial CT Ruff, RP Giugliano, E Braunwald, M Mercuri, V Curt, J Betcher, L Grip, ... Journal of the American College of Cardiology 64 (6), 576-584, 2014 | 63 | 2014 |
| Edoxaban vs. warfarin in vitamin K antagonist experienced and naive patients with atrial fibrillation ML O'Donoghue, CT Ruff, RP Giugliano, SA Murphy, LT Grip, MF Mercuri, ... European heart journal 36 (23), 1470-1477, 2015 | 56 | 2015 |
| Cerebrovascular events in 21 105 patients with atrial fibrillation randomized to edoxaban versus warfarin: Effective Anticoagulation with Factor Xa Next Generation in Atrial … RP Giugliano, CT Ruff, NS Rost, S Silverman, SD Wiviott, C Lowe, ... Stroke 45 (8), 2372-2378, 2014 | 52 | 2014 |
| Edoxaban versus warfarin in patients with atrial fibrillation and history of liver disease A Qamar, EM Antman, CT Ruff, F Nordio, SA Murphy, LT Grip, ... Journal of the American College of Cardiology 74 (2), 179-189, 2019 | 49 | 2019 |
| Effective aNticoaGulation with factor xA next GEneration in AF-Thrombolysis In Myocardial Infarction 48 Echocardiographic Study Investigators. Left atrial structure and … DK Gupta, AM Shah, RP Giugliano, CT Ruff, EM Antman, LT Grip, ... Eur Heart J 35 (22), 1457-65, 2014 | 37 | 2014 |
| Peri-operative adverse outcomes in patients with atrial fibrillation taking warfarin or edoxaban: analysis of the ENGAGE AF-TIMI 48 Trial JD Douketis, SA Murphy, EM Antman, LT Grip, MF Mercuri, CT Ruff, ... Thrombosis and Haemostasis 118 (06), 1001-1008, 2018 | 25 | 2018 |
| Feasibility and safety of low-dose intra-coronary tenecteplase during primary percutaneous coronary intervention for ST-elevation myocardial infarction (ICE T-TIMI 49) CM Gibson, V Kumar, L Gopalakrishnan, P Singh, J Guo, S Kazziha, ... The American journal of cardiology 125 (4), 485-490, 2020 | 19 | 2020 |
| Edoxaban versus Warfarin in high-risk patients with atrial fibrillation: A comprehensive analysis of high-risk subgroups B Gencer, A Eisen, D Berger, F Nordio, SA Murphy, LT Grip, C Chen, ... American Heart Journal 247, 24-32, 2022 | 18 | 2022 |
| Edoxaban versus warfarin in Latin American patients with atrial fibrillation: the ENGAGE AF-TIMI 48 trial R Corbalán, JC Nicolau, J López-Sendon, A Garcia-Castillo, R Botero, ... Journal of the American College of Cardiology 72 (13), 1466-1475, 2018 | 15 | 2018 |
| Atrial fibrillation and the ‘other drug problem’: reducing non-adherence with technology E Nerini, L Grip, AJ Camm, RP Giugliano European heart journal 34 (27), 2031-2033, 2013 | 11 | 2013 |
| New oral antithrombotic strategies: 2013 update on atrial fibrillation LT Grip, CT Ruff, RP Giugliano Hot Topics Cardiol 8 (31), 7-19, 2013 | 9 | 2013 |
| Edoxaban versus warfarin in patients with atrial fibrillation in relation to the risk of stroke: A secondary analysis of the ENGAGE AF-TIMI 48 study JR de Groot, CT Ruff, SA Murphy, RA Hamershock, JT Vehmeijer, ... American heart journal 235, 132-139, 2021 | 6 | 2021 |
| Efficacy and safety outcomes in 8040 women compared with 13085 men with atrial fibrillation treated with edoxaban vs warfarin for an average 2.8 years RP Giugliano, ML O’Donoghue, CT Ruff, P Merlini, F Nordio, LT Grip, ... J Atr Fibrillation, 2015 | 2 | 2015 |
| ENGAGE AF-TIMI 48 Primary Results RP Giugliano, CT Ruff, E Braunwald, SA Murphy, LT Grip, JM Betcher, ... Circulation 128 (24), 2711-2712, 2013 | 2 | 2013 |
